Citations

Clear

1434 citation(s) found for "Uk, Nathan".

Characteristics of Clinical Trial Sites for Novel Transcatheter Mitral and Tricuspid Valvular Therapies
Nathan, Ashwin S. , Reddy, Kriyana P. , Yang, Lin , Dayoub, Elias J. , Julien, Howard , Szeto, Wilson Y. , Kobayashi, Taisei , Fiorilli, Paul N. , Batchelor, Wayne , Giri, Jay , Kobayashi, Taisei J , Eberly, Lauren A. , Khatana, Sameed Ahmed M. , Desai, Nimesh D. , Herrmann, Howard C. , Mehran, Roxana , Alkhouli, Mohamad , Groeneveld, Peter W , Fanaroff, Alexander C.

Mayo Clinic

JAMA Cardiology | December 7, 2022 | Volume: 8 | Issue: 2 | Pages: 120

10.1001/jamacardio.2022.4457 | PMID 36477493 Get It

ImportanceRacial and ethnic minority and socioeconomically disadvantaged patients have been underrepresented in randomized clinical trials. Efforts have focused on enhancing inclusion of minority groups at sites participating at clinical trials; however, there may be differences in the patient populations of the sites that participate in clinical trials.ObjectiveTo identify any differences in the racial, ethnic, and socioeconomic composition of patient populations among candidate sites in the US that did vs did not participate in trials for novel transcatheter therapies.Design, Setting, and ParticipantsThis cross-sectional analysis used Medicare Provider Claims from 2019 for patients admitted to hospitals in the US. All clinical trials for transcatheter mitral and tricuspid valve therapies and the hospitals participating in each of the trials were identified using ClinicalTrials.gov. Hospitals with active cardiac surgical programs that did not participate in the trials were also identified. Data analysis was performed between July 2021 and July 2022.ExposuresMultivariable linear regression models were used to identify differences in racial, ethnic, and socioeconomic characteristics among patients undergoing cardiac surgery or transcatheter aortic valve replacement at trial vs nontrial hospitals.Main Outcome and MeasuresThe main outcome of the study was participation in a clinical trial for novel transcatheter mitral or tricuspid valve therapies.ResultsA total of 1050 hospitals with cardiac surgery programs were identified, of which 121 (11.5%) participated in trials for transcatheter mitral or tricuspid therapies. Patients treated in trial hospitals had a higher median zip code–based household income (difference of $5261; 95% CI, $2986-$7537), a lower Distressed Communities Index score (difference of 5.37; 95% CI, 2.59-8.15), and no significant difference in the proportion of patients dual eligible for Medicaid (difference of 0.86; 95% CI, −2.38 to 0.66). After adjusting for each of the socioeconomic indicators separately, there was less than 1% difference in the proportion of Black and Hispanic patients cared for at hospitals participating vs not participating in clinical trials.Conclusions and RelevanceIn this cohort study among candidate hospitals for clinical trials for transcatheter mitral or tricuspid valve therapies, trial hospitals took care of a more socioeconomically advantaged population than nontrial hospitals, with a similar proportion of Black and Hispanic patients. These data suggest that site selection efforts may improve enrollment of socioeconomically disadvantaged patients but may not improve the enrollment of Black and Hispanic patients.
Application of Shear-Wave Elastography in the Evaluation of Hamstring Stiffness in Young Basketball Athletes
Cummings, Paige , Schilaty, Nathan D. , Schilaty, Nathan D , Nagai, Takashi , Rigamonti, L , Bates, Nathaniel A. , Ueno, Ryo

Mayo Clinic

International Journal of Sports Physical Therapy | December 1, 2022 | Volume: 17 | Issue: 7 | Pages: No page available

10.26603/001c.55757 | PMID 36518841 Get It

Background Previous literature has postulated a relationship between greater hamstring stiffness and a higher risk of sustaining injury. Shear wave elastography (SWE) presents a relatively new means for non-invasive evaluation of soft tissue elasticity pre- and post- injury or intervention. Purpose 1. (1) To establish baseline hamstring stiffness measures for young competitive athletes and (2) determine effect of targeted neuromuscular training (TNMT) on shear wave stiffness of the hamstring. Study Design Un-blinded, prospective, non-randomized, cohort study. Methods Six-hundred forty-two lower extremities from 321 high school and collegiate basketball athletes (177 F: 139 M) were examined for hamstring stiffness prior to the start of their competitive basketball season. Teams were cluster assigned to either the control or intervention (TNMT) group. Subjects in the control group underwent regular season activities as directed, with no influence from the research team. For the TNMT group, the research team introduced a hamstring targeted dynamic warm-up program as an intervention focused on activating the hamstring musculature. Results Collegiate status was significant to hamstring stiffness for both sexes (p ≤ 0.02), but hamstring stiffness did not correlate to age or sex (r 2 ≤ 0.08). Intervention was a significant factor to hamstring stiffness when the hip was positioned in extension (p ≤ 0.01), but not in deeper flexion (p = 0.12). This effect was sex-specific as TNMT influenced hamstring stiffness in females (p = 0.03), but not in males (p ≥ 0.13). Control athletes suffered three HAM injuries; TNMT athletes suffered 0 hamstring injuries. Conclusion Higher SWE measurements correlated with increased risk of injury, male sex, and collegiate athletics. TNMT intervention can lessen muscle stiffness which may reduce relate to injury incidence. Intervention effectiveness may be sex specific. Level of Evidence II
The BCL-2 Inhibitor Venetoclax Augments Immune Effector Function Mediated by Fas Ligand, TRAIL, and Perforin/Granzyme B, Resulting in Reduced Plasma Viremia and Decreased HIV Reservoir Size during Acute HIV Infection in a Humanized Mouse Model
Chandrasekar, Aswath P. , Cummins, Nathan W. , Natesampillai, Sekar, Misra, Anisha , Alto, Alecia , Laird, Greg M., Laird, Greg , Cummins, Nathan W , Badley, Andrew D.

Mayo Clinic

Journal of Virology | November 30, 2022 | Volume: 96 | Issue: 24 | Pages: No page available

10.1128/jvi.01730-22 | PMID 36448802 Get It

This study is the first to examine the applicability of BCL-2 inhibition in the setting of active HIV infectionin vivo. Furthermore, this study demonstrates that venetoclax significantly enhances target cell killing induced by Fas ligand, TRAIL, and perforin/granzyme B and synergistically enhances autologous NK and CD8 cells’ killing of target cells.
Thromboelastography Parameters do not Discriminate for Thrombotic Events in Hospitalized Patients With COVID-19
Kartiko, Susan , Yamane, David , Siddique, Abu Bakkar , Levine, Andrea R. , Jackson, Amanda, Wieruszewski, Patrick M. , Smischney, Nathan J. , Chow, Jonathan H. , Investigators, for the CRUSH COVID, Levine, Andrea R , Wieruszewski, Patrick M , Smischney, Nathan J , Chow, Jonathan H , Koizumi, Naoru , Sarani, Babak , Khanna, Ashish K. , Investigators, for the CRUSH COVID

Mayo Clinic

Journal of Intensive Care Medicine | November 30, 2022 | Volume: 38 | Issue: 5 | Pages: 449-456

10.1177/08850666221142265 | PMID 36448250 Get It

Background Coronavirus disease 2019 (COVID-19) is associated with a prothrombotic state; leading to multiple sequelae. We sought to detect whether thromboelastography (TEG) parameters would be able to detect thromboembolic events in patients hospitalized with COVID-19. Methods We performed a retrospective multicenter case–control study of the Collaborative Research to Understand the Sequelae of Harm in COVID (CRUSH COVID) registry of 8 tertiary care level hospitals in the United States (US). This registry contains adult patients with COVID-19 hospitalized between March 2020 and September 2020. Results A total of 277 hospitalized COVID-19 patients were analyzed to determine whether conventional coagulation TEG parameters were associated with venous thromboembolic (VTE) and thrombotic events during hospitalization. A clotting index (CI) >3 was present in 45.8% of the population, consistent with a hypercoagulable state. Eighty-three percent of the patients had clot lysis at 30 min (LY30) = 0, consistent with fibrinolysis shutdown, with a median of 0.1%. We did not find TEG parameters (LY30 area under the receiver operating characteristic [ROC] curve [AUC] = 0.55, 95% CI: 0.44-0.65, P value = .32; alpha angle [α] AUC = 0.58, 95% CI: 0.47-0.69, P value = .17; K time AUC = 0.58, 95% CI: 0.46-0.69, P value = .67; maximum amplitude (MA) AUC = 0.54, 95% CI: 0.44-0.64, P value = .47; reaction time [R time] AUC = 0.53, 95% CI: 0.42-0.65, P value = .70) to be a good discriminator for VTE. We also did not find TEG parameters (LY30 AUC = 0.51, 95% CI: 0.42-0.60, P value = .84; R time AUC = 0.57, 95%CI: 0.48-0.67, P value .07; α AUC = 0.59, 95%CI: 0.51-0.68, P value = .02; K time AUC = 0.62, 95% CI: 0.53-0.70, P value = .07; MA AUC = 0.65, 95% CI: 0.57-0.74, P value < .01) to be a good discriminator for thrombotic events. Conclusions In this retrospective multicenter cohort study, TEG in COVID-19 hospitalized patients may indicate a hypercoagulable state, however, its use in detecting VTE or thrombotic events is limited in this population.
Deep learning-based optical coherence tomography image analysis of human brain cancer
Wang, Nathan , Lee, Cheng-Yu , Park, Hyeon‐Cheol , Chaichana, Kaisorn L. , Quiñones‐Hinojosa, Alfredo , Li, Xingde , Nauen, David W. , Bettegowda, Chetan

Mayo Clinic

Biomedical Optics Express | November 29, 2022 | Volume: 14 | Issue: 1 | Pages: 81

10.1364/boe.477311 | PMID 36698668 Get It

Real-time intraoperative delineation of cancer and non-cancer brain tissues, especially in the eloquent cortex, is critical for thorough cancer resection, lengthening survival, and improving quality of life. Prior studies have established that thresholding optical attenuation values reveals cancer regions with high sensitivity and specificity. However, threshold of a single value disregards local information important to making more robust predictions. Hence, we propose deep convolutional neural networks (CNNs) trained on labeled OCT images and co-occurrence matrix features extracted from these images to synergize attenuation characteristics and texture features. Specifically, we adapt a deep ensemble model trained on 5,831 examples in a training dataset of 7 patients. We obtain 93.31% sensitivity and 97.04% specificity on a holdout set of 4 patients without the need for beam profile normalization using a reference phantom. The segmentation maps produced by parsing the OCT volume and tiling the outputs of our model are in excellent agreement with attenuation mapping-based methods. Our new approach for this important application has considerable implications for clinical translation.
Regional pedicled flap salvage options for large head and neck defects: The old, the new, and the forgotten
Chang, Brent A. , Horwich, Peter , Hayden, Richard E. , Horwich, Peter M , Nathan, Cherie-Ann O , Chang, Brent A , Asarkar, Ameya A

Mayo Clinic

Laryngoscope Investigative Otolaryngology | November 29, 2022 | Volume: 8 | Issue: 1 | Pages: 63-75

10.1002/lio2.983 | PMID 36846409 Get It

AbstractObjectivesThe objective of this article is to review options for regional pedicled reconstruction for large head and neck defects in a salvage setting.MethodsRelevant regional pedicled flaps were identified and reviewed. Expert opinion and supporting literature were used to summarize and describe the available options.ResultsSpecific regional pedicled flap options are presented including the pectoralis major flap, deltopectoral flap, supraclavicular flap, submental flap, latissimus flap, and trapezius flap.ConclusionsRegional pedicled flaps are useful options in a salvage setting even for large defects and should be in the armamentarium of any reconstructive head and neck surgeon. Each flap option carries specific characteristics and considerations.
Early and Sustained Undetectable Measurable Residual Disease (MRD) after Idecabtagene Vicleucel (ide-cel) Defines a Subset of Multiple Myeloma (MM) Patients in Karmma Achieving Prolonged Survival
Manrique, Irene , Campbell, Timothy , Kazanecki, Christian C. , Martin, Nathan , Kaiser, Shari M. , Anderson, Larry D. , Lin, Yi , Munshi, Nikhil C. , Anderson, Larry D , Paiva, Bruno , Rytlewski, Julie , Berdeja, Jesús G. , Lonial, Sagar , Raje, Noopur , Moreau, Philippe , Miguel, Jesús F. San

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2104-2105

10.1182/blood-2022-166658 Get It

A Comparison of Financial Hardship Among Survivors of Childhood Cancer Treated with and without Hematopoietic Cell Transplantation: A Report from the Childhood Cancer Survivor Study
Buchbinder, David , Wang, Huiqi , Huang, I‐Chan , Yabroff, K. Robin , Khera, Nandita , Yabroff, K Robin , Bhatt, Neel S. , Yasui, Yutaka , Armenian, Saro H. , Bhatia, Smita , Chow, Eric J. , Kirchhoff, Anne C. , Leisenring, Wendy M. , Armstrong, Gregory T. , Nathan, Paul C.

Mayo Clinic

Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 10981-10982

10.1182/blood-2022-159132 Get It